1/The hardest thread yet! Are you up for the challenge?
How stroke perfusion imaging works!
Ever wonder why it’s Tmax & not Tmin?
Here’s what to know from @theAJNR SCANtastic!
https://t.co/2o9S3rVp6X
Our work just got published. Check it out!
Racial and Ethnic Diversity in Clinical Trials for Disease Modifying Drugs in Parkinson Disease: A Systematic Review & Meta‐Analysis - https://t.co/W2dLhRyG92
#NeuroTwitter#MovementDisorders#Parkinsons
1/The medulla is anything but DULL!
Does seeing an infarct in the medulla cause your heart to skip a beat?
Does medullary anatomy send you into respiratory arrest?
Never fear, here is a thread on the major medullary syndromes!
Amazing way to finish my last long vacations of med school before starting electives 🤩🥳 . Now I’m heading back to Brazil and probably staying away from X due to local restrictions 🫤
These past few days had been wicked cool 😎. I was able to present an abstract with the guidance of prestigious @dilucadaniel at #MDSCongress and meet incredible people. Loved Philly!! Already waiting for the next editions 🤞🤩 @movedisorder
As the MDS Young Members Group leading crew, we made a lil website for #MDSCongress attendees who are eager to check out Philly, our #MDSCongress sessions and our team. Check it out and please share! Edits? Let me know! https://t.co/v2586fN09R
Yes, we have a giant QR code too:
Can’t wait to connect with colleagues and mentors at International Congress of Parkinson’s Disease and Movement Disorders. 1 month and counting ⏳ @movedisorder#MDSCongress#Neurology#Neurotwitter
Yesterday I had the pleasure of running
to celebrate @ufvbr’s 98th birthday. Also got the 3rd position at my age category. I’m so proud of my progress so far 🥉🏃♂️🥳
Happy to announce that our work was published on @JSCVD2. Check it out ⬇️
The effect of sodium-glucose transporter 2 inhibitors on stroke in patients with type 2 diabetes: A meta-analysis - Journal of Stroke and Cerebrovascular Diseases https://t.co/SCVclp5dxJ
A child presenting with glomerulonephritis + PMH of a viral infx...
PSGN: low complement levels + sx occurring 2-3 weeks after the infx
IgA nephropathy: normal complement levels + shorter onset of sx (IgA has a weak complement-fixing activity)
#step2ck#USMLE
When treating thyrotoxicosis, a beta-blocker should be used, because hyperthyroidism causes upregulation of beta-adrenergic receptors. Then, give PTU (inhibits peripheral conversion of T4 to T3)
#step2ck